Cargando…
In Vitro Treatment of Melanoma Brain Metastasis by Simultaneously Targeting the MAPK and PI3K Signaling Pathways
Malignant melanoma is the most lethal form of skin cancer, with a high propensity to metastasize to the brain. More than 60% of melanomas have the BRAF(V600E) mutation, which activates the mitogen-activated protein kinase (MAPK) pathway [1]. In addition, increased PI3K (phosphoinositide 3-kinase) pa...
Autores principales: | Daphu, Inderjit, Horn, Sindre, Stieber, Daniel, Varughese, Jobin K., Spriet, Endy, Dale, Hege Avsnes, Skaftnesmo, Kai Ove, Bjerkvig, Rolf, Thorsen, Frits |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057758/ https://www.ncbi.nlm.nih.gov/pubmed/24840574 http://dx.doi.org/10.3390/ijms15058773 |
Ejemplares similares
-
In vivo models of primary brain tumors: pitfalls and perspectives
por: Huszthy, Peter C., et al.
Publicado: (2012) -
A Novel Nanoprobe for Multimodal Imaging Is Effectively Incorporated into Human Melanoma Metastatic Cell Lines
por: Aasen, Synnøve Nymark, et al.
Publicado: (2015) -
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
por: Nymark Aasen, Synnøve, et al.
Publicado: (2019) -
Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
por: Sundstrøm, Terje, et al.
Publicado: (2019) -
How well is the electronic health record supporting the clinical tasks of hospital physicians? A survey of physicians at three Norwegian hospitals
por: Schopf, Thomas Roger, et al.
Publicado: (2019)